Galapagos Genomics Receives Grants to Expand Functional Genomics Platform
20 juin 2002 07h49 HE
|
Galapagos Genomics
MECHELEN, Belgium, June 20, 2002 (PRIMEZONE) -- Galapagos Genomics, the Belgian/Dutch functional genomics company, announced today that it has been awarded technology development grants in Belgium...
Robin Brown Joins Galapagos Genomics as Chief Scientific Officer
21 mai 2002 07h52 HE
|
Galapagos Genomics
MECHELEN, Belgium, May 21, 2002 (PRIMEZONE) -- Galapagos Genomics NV today announced that Robin Brown has been appointed Chief Scientific Officer (CSO). Dr. Brown will be responsible for directing...
Galapagos Genomics Raises Euro21.4 Million in Private Placement
05 mars 2002 07h51 HE
|
Galapagos Genomics
MECHELEN, Belgium, March 5, 2002 (PRIMEZONE) -- Galapagos Genomics, the Belgian/Dutch functional genomics company, today announced the completion of a Euro21.4 million private placement. This first...
Galapagos Genomics and Exelixis Collaborate in Gene Function Analysis
23 janv. 2002 08h27 HE
|
Galapagos Genomics
MECHELEN, Belgium, Jan. 23, 2002 (PRIMEZONE) -- Galapagos Genomics NV, the Belgian functional genomics company, today announced a research collaboration with Exelixis, Inc., for the use of Galapagos'...
Galapagos Genomics Receives US Patent for its PhenoSelect Platform
23 janv. 2002 08h25 HE
|
Galapagos Genomics
MECHELEN, Belgium, Jan. 23, 2002 (PRIMEZONE) -- Galapagos Genomics NV, the Belgian functional genomics company, today announced that it has been awarded US Patent No. 6,340,595 entitled "High...
Galapagos Genomics and Euroscreen Enter into a Collaboration on G-Protein Coupled Receptors
10 déc. 2001 08h20 HE
|
Galapagos Genomics
MECHELEN and BRUSSELS, Belgium, Dec. 10, 2001 (PRIMEZONE) -- Galapagos Genomics NV, the Belgian functional genomics company, and Euroscreen SA, the Belgian G-protein coupled receptor (GPCR) company,...